Nico Buettner

MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma

Víctor H. Engelhard, Rebecca C. Obeng, Kara L. Cummings et al. · Journal for ImmunoTherapy of Cancer · 2020 · 82 citations · Full text

Life Sciences, Immunology, Oncology +17

Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis

Rouven Hoefflin, Adriana Lazarou, Maria Elena Hess et al. · Cancers · 2021 · 56 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis

Dominik Bettinger, David J. Pinato, Michael Schultheiß et al. · Liver Cancer · 2018 · 41 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Inefficient induction of circulating TAA-specific CD8+ T-cell responses in hepatocellular carcinoma

Catrin Tauber, Michael Schultheiß, Raffaele De Luca et al. · Oncotarget · 2019 · 40 citations · Full text

Life Sciences, Immunology, Oncology +17

Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS)

Lukas Sturm, Dominik Bettinger, Max Giesler et al. · United European Gastroenterology Journal · 2018 · 39 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14